Bernard Lisitza

A tough retirement nest egg, the whistle-blowing way

A tough retirement nest egg, the whistle-blowing way

By

Two big reactions hit me when news of Johnson & Johnson's $2.2 billion Risperdal settlement with the government landed this week. First, J&J probably made a lot more than it's paying out and, second, some individual probably is going to cash a nice paycheck for bringing it all to light.